Related Experiment Video
Updated: Jun 5, 2026

Mechanism of Kemeng Fang's Inhibition of Podocyte Apoptosis in Rats with Membranous Nephropathy through the PI3K/AKT Signaling Pathway
Published on: August 23, 2024
Wnt antagonist DICKKOPF-3 (Dkk-3) induces apoptosis in human renal cell carcinoma
Koji Ueno1, Hiroshi Hirata, Shahana Majid
1Department of Urology, Veterans Affairs Medical Center and University of California, San Francisco, California 94121, USA.
Abstract:
The Wnt signaling pathway is activated in most cancers while Wnt antagonist genes are inactivated. However, the functional significance and mechanisms of inactivation of Wnt antagonist Dkk-3 gene in renal cell carcinoma (RCC) has not been reported. In this study, we examined potential epigenetic mechanisms regulating Dkk-3 expression in RCC cells and whether Dkk-3 expression affects cell growth and apoptosis. The expression of Dkk-3 is regulated by histone modification rather than CpG island DNA methylation in renal cancer cells. Renal cancer cell proliferation was significantly inhibited and apoptosis was promoted in Dkk-3 transfected renal cancer cells. Dkk-3 did not inhibit the Wnt/beta-catenin signaling pathway but induced apoptosis via the noncanonical JNK pathway in renal cancer cells. Expression of p21, MDM-2, and Puma genes were increased after transfecting RCC cell lines with a Dkk-3 expression plasmid. Overexpression of Dkk-3 induced G(0)/G(1) arrest together with an increase in p21 expression. Growth of stable Dkk-3 transfected cells in nude mice was decreased compared to controls. Our data show for the first time that mRNA expression of Dkk-3 is regulated by histone modification and that Dkk-3 inhibits renal cancer growth through modulation of cell cycle and apoptotic pathways.
Insights
Dickkopf-3 (Dkk-3) gene inactivation in renal cell carcinoma (RCC) is regulated by histone modification. Dkk-3 inhibits renal cancer growth by promoting apoptosis and cell cycle arrest, independent of the Wnt/beta-catenin pathway.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Wnt signaling pathway activation is common in cancers.
- Wnt antagonist genes, like Dkk-3, are often inactivated in tumors.
- Mechanisms of Dkk-3 inactivation in renal cell carcinoma (RCC) remain unclear.
Purpose of the Study:
- Investigate epigenetic mechanisms regulating Dkk-3 expression in RCC.
- Determine the functional impact of Dkk-3 on RCC cell growth and apoptosis.
- Elucidate the signaling pathways involved in Dkk-3-mediated effects.
Main Methods:
- Analysis of Dkk-3 expression in RCC cells.
- Assessment of CpG island DNA methylation and histone modification.
- Transfection of RCC cell lines with Dkk-3 expression plasmid.
- Evaluation of cell proliferation, apoptosis, and cell cycle progression.
- In vivo tumor growth studies in nude mice.
Main Results:
- Dkk-3 expression is regulated by histone modification, not DNA methylation, in RCC.
- Dkk-3 transfection inhibited renal cancer cell proliferation and promoted apoptosis.
- Dkk-3 induced apoptosis via the noncanonical JNK pathway, not Wnt/beta-catenin.
- Dkk-3 overexpression led to G(0)/G(1) arrest and increased p21 expression.
- Tumor growth was reduced in vivo in Dkk-3-expressing cells.
Conclusions:
- Dkk-3 mRNA expression in renal cancer is epigenetically regulated by histone modification.
- Dkk-3 acts as a tumor suppressor in RCC by modulating cell cycle and apoptosis.
- Dkk-3 inhibits renal cancer progression through noncanonical JNK and cell cycle pathways.
Related Concept Videos
Canonical Wnt Signaling Pathway
Non-Canonical Wnt Signaling Pathways
Inhibition of Cdk Activity
The Extrinsic Apoptotic Pathway

